The importance of being heterozygote: effects of RHD-genotype-sex interaction on the physical and mental health of a non-clinical population

• Published in: Scientific reports Vol. 11; no. 1; pp. 21960 - 8
• Main Authors: Flegr, Jaroslav, Příplatová, Lenka, Hlaváčová, Jana, Šebánková, Blanka, Žďárský, Emanuel, Kaňková, Šárka
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 09.11.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/181; 631/208; 631/443; 692/499; 692/699; Adult; Female; Fertility; Fetuses; Gene polymorphism; Genotype; Genotype & phenotype; Genotypes; Hemolytic disease; Heterozygote; Heterozygotes; Homozygotes; Human populations; Humanities and Social Sciences; Humans; Immunization; Male; Mental Health; multidisciplinary; Phenotypes; Polymorphism; Rh-Hr Blood-Group System - genetics; Science; Science (multidisciplinary); Sex Factors; Young Adult
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-00977-1

Human populations, especially European, are polymorphic in the RHD gene. A significant fraction of their members carry no copy of the coding section of RHD gene, which results in their Rh-negative blood type. Theoretically, this polymorphism should be unstable. Carriers of the less frequent allele are penalized by reduced fertility because of the immunization of RhD-negative mothers by their RhD-positive babies, which results in hemolytic disease of the fetus and newborn in their subsequent progeny. For about 90 years, some form of balancing selection has been suspected to sustain this polymorphism. Several recent studies showed that the RhD-positive heterozygotes express higher viability than both types of homozygotes. However, the genotype of subjects in these studies was estimated only by indirect methods. Here we compared the physical and mental health of 178 women and 86 men who were directly tested for their RHD genotype. The results showed that RhD-positive homozygotic women had worse and RhD-positive homozygotic men better physical health than RhD-negative homozygotes; the difference between RhD-negative homozygotes and heterozygotes was not significant. Our results confirmed that health of RhD-positive heterozygotes and homozygotes differ. Therefore, any result of the comparison of subjects with RhD-positive and RhD-negative phenotype depends on the heterozygote-to-homozygote ratio in the RhD-positive sample. It is, therefore, crucial to analyze the effects of RHD -genotypes, not phenotypes in future studies.